Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Adler

Showing results (671-680 of 830) with videos related to

Pageof 83
Sort By:
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Neurology|July 1, 2014
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyCharles H Adler, Thomas G Beach, Joseph G Hentz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Parkinson Disease Neuropathological Comorbidities: Prevalences from Younger-Old to Older-Old, With Comparison to Non-Demented, Non-Parkinsonian SubjectsThomas G Beach, Geidy E Serrano, Erika D Driver-Dunckley, et al.
Clinical and Experimental Immunology|March 5, 1998
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLAP V Baskar, G D Collins, B A Dorsey-Cooper, et al.
Acta Neuropathologica|November 7, 2007
Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseThomas Gerald Beach, Charles H Adler, Lucia I Sue, et al.
Annals of Neurology|May 7, 2026
Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's DiseaseShannon Y Chiu, Wei-En Wang, Robin Chen, et al.
Acta Neuropathologica|November 5, 2008
Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disordersThomas G Beach, Charles L White, Christa L Hladik, et al.
Nature Communications|August 5, 2025
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplificationSophie E Mastenbroek, Lyduine E Collij, Jacob W Vogel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaLih-Fen Lue, Christopher T Schmitz, Noelle L Snyder, et al.
Dysphagia|June 5, 2015
Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease PatientsLiancai Mu, Jingming Chen, Stanislaw Sobotka, et al.
Pageof 83

Showing results (671-680 of 830) with videos related to

Sort By:
Pageof 83
Biomarker Insights|March 28, 2013
Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathologyChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Neurology|July 1, 2014
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic studyCharles H Adler, Thomas G Beach, Joseph G Hentz, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Parkinson Disease Neuropathological Comorbidities: Prevalences from Younger-Old to Older-Old, With Comparison to Non-Demented, Non-Parkinsonian SubjectsThomas G Beach, Geidy E Serrano, Erika D Driver-Dunckley, et al.
Clinical and Experimental Immunology|March 5, 1998
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLAP V Baskar, G D Collins, B A Dorsey-Cooper, et al.
Acta Neuropathologica|November 7, 2007
Reduced striatal tyrosine hydroxylase in incidental Lewy body diseaseThomas Gerald Beach, Charles H Adler, Lucia I Sue, et al.
Annals of Neurology|May 7, 2026
Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's DiseaseShannon Y Chiu, Wei-En Wang, Robin Chen, et al.
Acta Neuropathologica|November 5, 2008
Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disordersThomas G Beach, Charles L White, Christa L Hladik, et al.
Nature Communications|August 5, 2025
Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplificationSophie E Mastenbroek, Lyduine E Collij, Jacob W Vogel, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2016
Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaLih-Fen Lue, Christopher T Schmitz, Noelle L Snyder, et al.
Dysphagia|June 5, 2015
Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease PatientsLiancai Mu, Jingming Chen, Stanislaw Sobotka, et al.
Pageof 83